6 KPIs a Med Spa Owner Should Track Before a PE Buyer Looks at the Practice

Recast (Adjusted) EBITDA and Add-Back Defensibility

Buyers price a med spa off adjusted EBITDA, not reported net income, so the add-backs behind that number matter as much as the multiple itself. At $1 million to $3 million in adjusted EBITDA, spas trade at 5.0x to 7.0x. Scale to $3 million to $10 million and the range moves to 7.0x to 10.0x. A sell-side Quality of Earnings review, which tests whether those add-backs actually survive scrutiny, typically runs $40,000 to $90,000 for a spa with a membership program and multiple service lines. Every add-back an owner cannot document, from personal expenses to a below-market medical director fee, gets stripped back out before the multiple is applied.

• At $1M to $3M in adjusted EBITDA, med spas trade at an observed range of 5.0x to 7.0x, median cluster 5.5x to 6.5x; scale to $3M to $10M in adjusted EBITDA and the range moves to 7.0x to 10.0x, median 8.0x to 9.5x.(CT Acquisitions, 2026 Med Spa and Medical Aesthetic M&A Multiples Report)
• A sell-side Quality of Earnings review typically costs $40,000 to $90,000 for a medspa with multiple service lines, a membership program, deferred revenue, and an MSO/PC structure, and a documented medical director fee at fair market value typically runs $30,000 to $80,000 a year.(CT Acquisitions, How to Prepare Your Medical Spa for a Sale or Exit)

Takeaway: The multiple only applies to earnings a buyer believes. Get a Quality of Earnings review before a buyer runs their own, so you know which add-backs actually hold up.

Top Practice CFO builds the normalized earnings bridge from your real ledger and documents every add-back the way a buyer's QoE firm will test it, so the number holds up months later, not just at the letter of intent.

Provider (Injector) Revenue Concentration

A buyer's single biggest key-person test is how much revenue rides on one person leaving. The published diligence bar is no single injector above 25 percent of injectable revenue, with the owner personally under 20 percent and under 30 hours a week of clinical work. Cross that line and it costs real multiple. When one provider drives more than 35 percent of total revenue, buyers apply a discount of roughly 0.5x to 1.0x turns. One advisory firm puts owner-injectors doing 60 percent or more of treatments at 3.5x to 5.0x, versus 7.0x to 9.0x for an owner who has moved into management.

• The diligence bar buyers test against is no single injector above 25 percent of injectable revenue, with the owner in management rather than the highest-volume injector, doing under 30 hours a week of clinical work and under 20 percent of injectable revenue.(CT Acquisitions, How to Prepare Your Medical Spa for a Sale or Exit)
• If any individual provider drives more than 35 percent of total revenue, buyers apply a discount typically worth 0.5x to 1.0x turns of the otherwise applicable multiple.(CT Acquisitions, 2026 Med Spa and Medical Aesthetic M&A Multiples Report)
• Practices where the owner personally performs 60 percent or more of treatments transact at 3.5x to 5.0x; practices where the owner has shifted into a management-only role transact at 7.0x to 9.0x and above.(Aesthetic Brokers)

Takeaway: Bring in a second and third trained injector years before a sale, not months, because the discount is priced on today's concentration, not next year's plan to fix it.

Top Practice CFO tracks revenue by provider every month, so concentration risk shows up as a number to fix on a timeline, not a surprise a buyer's advisor finds first.

Membership and Recurring-Revenue Share of Total Revenue

Predictable revenue is worth more than one-off revenue to a buyer underwriting future cash flow, and the market prices that difference directly into the multiple. A med spa with 30 to 40 percent of revenue from memberships can add roughly 0.5x to 1.0x versus an otherwise identical practice with no membership program. Two separate M&A advisory reports confirm that premium independently. The number that matters is the share of revenue that recurs without a new sale, not the sign-up count, because a membership program with heavy breakage or high churn doesn't earn the same premium.

• A practice with 30 to 40 percent revenue share from memberships can add 0.5x to 1.0x versus an otherwise-identical non-membership peer.(CT Acquisitions, 2026 Med Spa and Medical Aesthetic M&A Multiples Report)
• A practice with 30 to 40 percent of revenue from memberships is meaningfully more valuable than an identical practice without one; standalone med spas with recurring memberships and diversified treatments can reach 10x to 12x EBITDA versus 4x to 7x for a standalone spa without them.(Breakwater M&A, Medical Spa Valuation Multiples 2026)

Takeaway: Track membership revenue as a share of total revenue every month, the same number a buyer pulls first, and expect follow-up questions about breakage and churn, not just the sign-up count.

Top Practice CFO reports membership revenue as its own line, net of breakage and churn, so the recurring-revenue percentage you show a buyer is the real one, not the gross sign-up number.

Cash-Pay Revenue Purity (the Insurance-Mix Discount)

A pure med spa is a fully elective, cash-pay business, and buyers price a real penalty on any practice that has drifted toward insurance billing without cleanly separating that revenue. The target buyers underwrite to is 95 percent or higher cash-pay. Fall short because a slice of revenue routes through insurance, and buyers apply a discount of 0.5 to 1.5 turns of adjusted EBITDA. The fix isn't necessarily dropping medical dermatology work. It's tracking that revenue on its own schedule so a buyer can underwrite the cash-pay core at full value.

• The target buyers underwrite to is 95 percent or higher cash-pay revenue; the penalty for insurance-mix contamination runs 0.5x to 1.5x turns of adjusted EBITDA.(CT Acquisitions, 2026 Med Spa and Medical Aesthetic M&A Multiples Report)

Takeaway: Know your cash-pay percentage to the decimal before a buyer asks, and keep any insurance-billed revenue on a separate schedule so it doesn't drag down the multiple on the rest of the business.

Top Practice CFO separates cash-pay revenue from any insurance-billed work on its own ledger view, so a diligence team sees exactly what it's buying instead of one blended number.

Systems and Multi-Location Readiness (EMR, Monthly Close, and a Real KPI Dashboard)

A buyer underwriting a roll-up needs to trust the numbers fast, and that trust is built on infrastructure, not good intentions. The diligence bar is a modern medspa EMR in place for 18 or more months before a sale, with migrations commonly taking 3 to 9 months depending on scale. Add a monthly close finished within 15 days and a live KPI dashboard tracking average ticket, visits per patient per year, member MRR, ARR and churn, injector and aesthetician utilization, new-patient acquisition cost by channel, and review velocity. A single location with a management layer in place can already command 6.0x to 7.5x EBITDA, a meaningfully stronger band than an owner running everything out of a spreadsheet.

• The diligence target is a medspa EMR in place 18 or more months pre-sale, with migrations commonly taking 3 to 9 months depending on scale, a monthly close finished within 15 days, and a live KPI dashboard covering average ticket, visits per patient per year, member MRR, ARR and churn, injector and aesthetician utilization, new-patient acquisition cost by channel, and review velocity.(CT Acquisitions, How to Prepare Your Medical Spa for a Sale or Exit)
• For a $1M to $3M adjusted-EBITDA practice, a single location with a management layer in place, rather than the owner running every function personally, moves into the 6.0x to 7.5x EBITDA band, versus a materially lower band for an owner-dependent operation with no management layer.(Breakwater M&A, Medical Spa Valuation Multiples 2026)

Takeaway: Put the KPI dashboard and the 15-day close in place two years before a sale, not two months, because a buyer wants a track record, not a system that started the week the listing went out.

Top Practice CFO builds that same live dashboard, average ticket, member MRR and churn, utilization by provider, straight from your booking system and ledger, so it already exists before a buyer ever asks for it.

Client Retention and Repeat-Visit Rate

A buyer values a practice on the assumption that today's clients keep coming back, so retention is one of the clearest tells for whether that assumption is safe. Most med spas run a 50 to 70 percent client retention rate, with the top of that range concentrated in practices using structured treatment plans or memberships to keep a client's next visit already on the books. A spa converting well below 50 percent retention is effectively rebuilding its client base every year. That's a materially riskier earnings stream for a buyer to underwrite at a strong multiple.

• Most med spas run a 50 to 70 percent client retention rate, with the higher end of that range concentrated in clinics using structured treatment plans or memberships, and 3 to 6 visits per year per active patient, higher for clinics offering ongoing treatment plans.(OptiMantra, Med Spa Benchmarks 2026: Revenue, Retention & Utilization Rates)

Takeaway: Track retention as a real percentage, not a feeling that clients seem loyal, because it's one of the first numbers a buyer asks to see broken out by cohort.

Top Practice CFO tracks client retention and repeat-visit rate as its own monthly number, so a buyer sees a documented trend line instead of an owner's impression of loyalty.

How the 6 KPIs Compare, and How We Chose Them

These six were chosen because each one is something a PE buyer or an M&A advisor actually diligences, not a general profitability metric, and because each has a real, sourced benchmark or threshold attached to it. They're ordered from the number that sets the price, recast EBITDA, to the operational proof that the price is real: systems and retention. Fix the first three (EBITDA quality, provider concentration, membership share) and the multiple itself moves. Fix the last three (cash-pay purity, systems readiness, retention) and diligence goes faster with fewer surprises.

Takeaway: Start with recast EBITDA and provider concentration, because they move the multiple directly; the rest move how smoothly diligence goes once a number is on the table.

The 14-Day Financial X-ray checks all six of these against your real ledger, booking system, and payroll data, and hands back a written list of where you'd stand in diligence today, not a generic checklist.